Endovia Health Sciences, Inc. (EDVA) Return on equity 2016–2022
Endovia Health Sciences, Inc. (EDVA) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-232.7%FY2022 · since FY2016: -123.1% → -232.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | -232.7% | +94.7 pp |
| FY2021 | -327.4% | — |
| FY2016 | -123.1% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More EDVA financial trends
EDVA RevenueEDVA Net incomeEDVA Net marginEDVA Gross profitEDVA Gross marginEDVA Operating incomeEDVA Operating marginEDVA Operating cash flowEDVA Free cash flowEDVA Capital expendituresEDVA Stock buybacksEDVA Dividends paidEDVA Total assetsEDVA Total liabilitiesEDVA Shareholders’ equityEDVA overview →